Cipla Ltd
The live share price of Cipla Ltd (CIPLA) as on 19 Apr 10:16am is ₹1,345.75 from NSE/BSE.
CIPLA NSE
₹1,345.75 ▼-0.12% (-1.55)
As on Apr 19, 2024 03:46 PM IST
Key Metrics
PE Ratio
29.94
PB Ratio
4.68
Dividend Yield
0.62%
Sector PB
5.9
Sector PE
51.76
Sector Div Yld
0.56%
Dividend Yield
Dividend per share for the most recent financial year divided by the close price
About
Cipla Limited is a pharmaceutical company. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology & cosmetology, diabetes, HIV/AIDS, infectious diseases & critical care, malaria etc.
The following charts display the financial performance of the Cipla Ltd (CIPLA) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.
Furthermore, under the Peers section, you can find stocks that are similar to Cipla Ltd (CIPLA), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.
✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.
A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.
All smallcases are created and managed by SEBI-registered investment experts.
To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.
Financials
Income Statement
(INR) | Y/Y Change | |
Revenue | 23,228 Cr | +5.37% |
Operating Expense | 1,873 Cr | +60.18% |
Net Income | 2,801 Cr | +11.33% |
Net Profit Margin | 12.06% | +5.6% |
Earning Per Share | 34 | +11.28% |
EBITDA | 5,320 Cr | +14.37% |
Balance sheet
(INR) | Y/Y Change | |
Cash & short-term Inv | 4,654 Cr | +12.88% |
Total Assets | 29,300 Cr | +9.1% |
Total Liabilities | 5,586 Cr | -2.67% |
Total Equity | 23,713 Cr | +12.29% |
Shares Outstanding | 80.72 Cr | +0.05% |
Price to Book | 3.07 | -20.82% |
Return on Assets | 9.98% | +2.57% |
Return on Capital | 17.49 Cr | +2.58% |
Cash Flows
(INR) | Y/Y Change | |
Net Income | 2,801 Cr | +11.33% |
Cash from Operations | 3,237 Cr | -2.65% |
Cash from Investing | -2,376 Cr | +27.86% |
Cash from Financing | -958 Cr | -40.1% |
Net Change in Cash | -96 Cr | -26.86% |
Free Cash Flow | 2,054 Cr | -21.72% |
Peers
SUNPHARMA
Sun Pharmaceutical Industries Ltd
PE Ratio
41.42
1Y Return
▲50.92%
DRREDDY
Dr Reddy's Laboratories Ltd
PE Ratio
19.27
1Y Return
▲21.27%
ZYDUSLIFE
Zydus Lifesciences Ltd
PE Ratio
31.97
1Y Return
▲81.62%
MANKIND
Mankind Pharma Ltd
PE Ratio
52.91
1Y Return
▲68.43%
Latest News
Cipla Q4 PAT may dip 24.9% YoY to Rs 869.4 cr: ICICI Securities
3 days ago on Moneycontrol
Change since news ▼-INF%
Net Sales are expected to decrease by 4.7 percent Y-o-Y (up 9.6 percent Q-o-Q) to Rs 6,290.9 crore, according to ICICI Securities.
Cipla To Acquire Ivia Beaute Brands For Rs 130 Crore
4 days ago on Bloomberg Quint
Change since news ▼-INF%
Pharma major Cipla Ltd will acquire the cosmetics and personal care distribution and marketing business of Ivia Beaute Pvt Ltd, including the latter’s brands Astaberry, Ikin and Bhimsaini, on a worldwide basis for Rs 130 crore.
4 days ago on News18
Change since news ▼-INF%
Cipla says CHL has signed a Business Transfer Agreement for purchase of the distribution and marketing business undertaking of the cosmetics and personal care business of Ivia Beaute Pvt Ltd, Cipla to Acquire Ivia Beaute’s Cosmetics, Personal Care Distribution and Marketing Biz for Rs 130 Crore
FAQs on Cipla Ltd
How to buy Cipla Ltd stocks?
You can easily buy the stocks/shares of Cipla Ltd (CIPLA) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.
What is the Share Price of Cipla Ltd?
The stock price of Cipla Ltd as on 19 Apr 2024 is ₹1,345.75
What is the 52-week High and Low of Cipla Ltd?
The 52-week high and low of Cipla Ltd (CIPLA) is ₹1,519 and ₹896.3.
What is the PE and PB ratio of Cipla Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Cipla Ltd are 29.94 and 4.68 respectively.
What are the peers or stocks similar to Cipla Ltd?
The peers or stocks similar to Cipla Ltd are Sun Pharmaceutical Industries Ltd, Dr Reddy's Laboratories Ltd, Zydus Lifesciences Ltd, Mankind Pharma Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.
Which sector does Cipla Ltd belong to?
Cipla Ltd (CIPLA) belongs to the Pharmaceuticals sector.
What is the Market Cap of Cipla Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Cipla Ltd (CIPLA) is ₹1,11,029 Cr as of 19 Apr 2024
Can't decide whether or not to buy Cipla Ltd stocks? ⭐️
Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.